The Somatic POLE P286R Mutation Defines a Unique Subclass of Colorectal Cancer Featuring Hypermutation, Representing a Potential Genomic Biomarker for Immunotherapy

Oncotarget - United States
doi 10.18632/oncotarget.11862
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

BRAF Mutation as a Biomarker in Colorectal Cancer

Advances in Genomics and Genetics
2015English

The Somatic Mutation Landscape of Chinese Colorectal Cancer

Journal of Cancer
Oncology
2020English

Upregulation of WEE1 Is a Potential Prognostic Biomarker for Patients With Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2017English

TCR Diversity – A Universal Cancer Immunotherapy Biomarker?

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2016English

Immunotherapy and Pancreatic Cancer: Unique Challenges and Potential Opportunities

Therapeutic Advances in Medical Oncology
Oncology
2018English

Septin-9: A Novel Biomarker for Colorectal Cancer Screening

International Surgery Journal
2019English

Mitochondrial ND3 G10398A Mutation: A Biomarker for Breast Cancer

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

Finding a New Prognostic Biomarker for Metastatic Colorectal Cancer

Journal of the Korean Society of Coloproctology
2012English

Identification of a New Protein Biomarker for Colorectal Cancer Diagnosis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy